AlphaCrest Capital Management’s Microchip Technology MCHP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-19,809
Closed -$1.21M 680
2022
Q3
$1.21M Sell
19,809
-78,122
-80% -$5.13M 0.07% 487
2022
Q2
$5.69M Buy
97,931
+64,120
+190% +$4.25M 0.27% 51
2022
Q1
$2.54M Buy
33,811
+10,685
+46% +$804K 0.14% 168
2021
Q4
$2.01M Buy
23,126
+6,210
+37% +$502K 0.07% 424
2021
Q3
$1.3M Sell
16,916
-31,664
-65% -$2.37M 0.07% 497
2021
Q2
$3.64M Buy
48,580
+44,004
+962% +$3.35M 0.16% 176
2021
Q1
$355K Sell
4,576
-12,036
-72% -$898K 0.02% 952
2020
Q4
$1.15M Sell
16,612
-5,152
-24% -$321K 0.1% 273
2020
Q3
$1.12M Sell
21,764
-480
-2% -$25K 0.12% 223
2020
Q2
$1.17M Sell
22,244
-608
-3% -$27.4K 0.19% 111
2020
Q1
$775K Buy
+22,852
New +$1.07M 0.09% 380
2019
Q4
Sell
-46,822
Closed -$2.17M 1320
2019
Q3
$2.17M Buy
46,822
+22,884
+96% +$1.04M 0.13% 205
2019
Q2
$1.04M Buy
23,938
+13,454
+128% +$598K 0.09% 379
2019
Q1
$435K Buy
+10,484
New +$434K 0.07% 525

Other funds holding MCHP

AlphaCrest Capital Management's MCHP Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Microchip Technology (MCHP) in Q4 2022, closing a stake of 19,809 shares — an estimated $1.21M sold.

AlphaCrest Capital Management first reported a position in MCHP in Q1 2019 and held it in 14 quarters. The position peaked at $5.69M in Q2 2022. 1,090 funds tracked by Wall St. Rank hold MCHP as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Microchip Technology position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 19,809 Microchip Technology shares in Q4 2022, an estimated $1.21M.
  • AlphaCrest Capital Management first reported a position in Microchip Technology in Q1 2019 and held it in 14 quarters.
  • AlphaCrest Capital Management's Microchip Technology position peaked at $5.69M in Q2 2022.
  • 1,090 funds tracked by Wall St. Rank held Microchip Technology as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.